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Polychlorinated biphenyls (PCBs), polychlo-
rinated dibenzo-p-dioxins (PCDDs), and
polychlorinated dibenzofurans (PCDFs) (the
latter two are designated dioxins) are
lipophilic stable toxic compounds that occur
widely in the environment. They are presently
a pollution problem because they resist chem-
ical or biologic degradation and accumulate
in the food chain. Persistent neurobehavioral,
immunologic, reproductive, and endocrine
alterations were observed in experimental ani-
mals after in utero and lactational exposure to
PCBs and dioxins (1). Daily intake of PCBs
and dioxins per kilogram body weight is 50
times higher in nursing infants than in adults
(2); among Dutch preschool children, median
plasma PCB levels are 4 times higher in previ-
ously breast-fed than in formula-fed children
(3). PCBs and dioxins can cause a broad
range of immunotoxic effects in animals,
including decreased host resistance to infec-
tions and suppressed humoral and cell-medi-
ated immune responses (4). Because the
developing immune system is vulnerable, the
potential immunotoxic effects of perinatal
exposure to PCBs and dioxins are of particu-
lar concern. However, data regarding the
potential toxic effects of in utero and lacta-
tional exposure to PCBs and dioxins in
humans are scarce. In 1979, an episode of
poisoning from ingestion of rice oil contami-
nated with PCBs and PCDFs occurred in
central Taiwan (Yu-Cheng). Among children
born to these highly exposed women,
researchers found a higher incidence of respi-
ratory symptoms during the ﬁrst six months
after birth (5) and of middle-ear diseases at
school age (6). In Inuit infants, whose moth-
ers have high levels of organochlorine com-
pounds in their breast milk, perinatal
organochlorine exposure was associated with
more acute otitis media in the ﬁrst year of life
(7). In a previous paper (8) we concluded that
prenatal exposure to PCBs and dioxins was
associated with changes in the T-cell lympho-
cyte population in Dutch infants. No effect
on the health status nor on humoral immuni-
ty was found. However, there is concern that
such early subtle changes could persist into
later childhood and could presage difﬁculties,
such as immune suppression or allergy. In this
paper we report on the immunologic effects
of perinatal background exposure to PCBs
and dioxins in Dutch preschool children. We
investigated whether exposure to PCBs and
dioxins is associated with the prevalence of
infectious or allergic diseases, changes in anti-
body responses, or changes in lymphocyte
phenotype determinations in Dutch children
at preschool age.
Methods
Subjects. The total study group consisted of
207 healthy Caucasian mother–infant pairs,
recruited between June 1990 and February
1992. Characteristics of the study group are
described elsewhere (3,9). Pregnancy and deli-
very were uncomplicated. Only ﬁrst- or sec-
ond-born infants at term (37–42 weeks of
gestation) without congenital anomalies,
diseases, or perinatal complications were
included. One hundred five infants were
breast-fed for at least 6 weeks, and 102 infants
were exclusively bottle-fed with formula from
a single batch (Almiron M2; Nutricia NV,
Zoetermeer, The Netherlands) until 7
months of age. In this formula concentrations
of both PCBs and dioxins were not
detectable. The study protocol was approved
by the medical ethics committee of the
University Hospital Rotterdam/Sophia
Children’s Hospital. Informed consent was
given by the parents.
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Prenatal exposure to polychlorinated biphenyls (PCBs) and dioxins is associated with changes in
the T-cell lymphocyte population in healthy Dutch infants. We investigated whether these
changes persist into later childhood and whether background exposure to PCBs and dioxins is
associated with the prevalence of infectious or allergic diseases and humoral immunity at
preschool age. The total study group consisted of 207 healthy mother–infant pairs. We estimated
prenatal exposure to PCBs and dioxins by the sum of PCBs 118, 138, 153, and 180 (Σ PCB) in
maternal and cord plasma and in breast-fed infants by the dioxin, planar, and mono-ortho PCB
toxic equivalent (TEQ) levels in human milk. At 42 months of age, current body burden was esti-
mated by the Σ PCB in plasma. We assessed the prevalence of infectious and allergic diseases by
parent questionnaire, and measured humoral immunity by antibody levels for mumps, measles,
and rubella after primary vaccination. We performed immunologic marker analyses of lympho-
cytes in a subgroup of 85 children. Prenatal PCB exposure was associated with an increased num-
ber of lymphocytes, T-cells, and CD3CD8+ (cytotoxic), CD4+CD45RO+ (memory), T-cell recep-
tor (TcR) αβ +, and CD3+HLA-DR+ (activated) T cells and lower antibody levels to mumps and
measles at preschool age. Adjusted for confounders, prenatal PCB exposure was associated with
less shortness of breath with wheeze, and current PCB body burden was associated with a higher
prevalence of recurrent middle-ear infections and of chicken pox and a lower prevalence of allergic
reactions. A higher dioxin TEQ was associated with a higher prevalence of coughing, chest con-
gestion, and phlegm. We conclude that in Dutch preschool children the effects of perinatal back-
ground exposure to PCBs and dioxins persist into childhood and might be associated with a
greater susceptibility to infectious diseases. Common infections acquired early in life may prevent
the development of allergy, so PCB exposure might be associated with a lower prevalence of aller-
gic diseases. Key words: allergic diseases, antibody levels, breast-feeding, infectious diseases, leuco-
cyte (sub)populations, PCBs, PCDDs, PCDFs. Environ Health Perspect 108:1203–1207 (2000).
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ins. We estimated prenatal exposure to PCBs
and dioxins by the sum of four PCB con-
geners (PCB 118, 138, 153, and 180) in
maternal and cord plasma (Σ PCB maternal
and Σ PCB cord), and in breast-fed infants by
the dioxin, planar, and mono-ortho PCB toxic
equivalent (TEQ) levels in human milk. To
express the total toxic potency of PCDDs,
PCDFs, and dioxin-like PCBs, we used the
toxic equivalent factor (TEF) approach
according to the World Health Organization
(10). We deﬁned current PCB body burden
as the sum of the four PCB congeners in plas-
ma from 42-month-old children (Σ PCB 42
months). Methods of determination, labora-
tory validation, and quality control were
described previously (3,9).
Measures of immunologic effects. At the
end of the 42-month follow-up period, we
sent a health questionnaire to all parents, cov-
ering topics regarding infectious and allergic
diseases as well as potential confounding vari-
ables such as tobacco smoking, family history
of atopy (asthma, bronchitis, hay fever, or
eczema in ﬁrst-degree relatives), and day care
or nursery school attendance of the child.
Parents were asked whether a doctor had ever
given the child a diagnosis of otitis media,
pneumonia, scarlatina, chicken pox, rubella,
measles, mumps, pertussis, hepatitis, meningi-
tis, or other infectious diseases. Additional
questions included: Has your child ever had
eczema or an allergic reaction? Has a doctor
ever said to you that your child had asthma or
bronchitis? Has your child had periods of
coughing, chest congestion, or phlegm lasting
for 10 days or attacks of shortness of breath
with wheeze in the previous 12 months?
Primary vaccinations against mumps,
measles, and rubella were given to 206 of the
207 children at approximately 14 months of
age as part of the National Immunization
Program. The vaccines were manufactured
by the National Institute of Public Health
and the Environment and given at the local
municipal health service. When the children
were 42 months of age, humoral antibody
levels (IgG) in plasma were measured against
measles, mumps, and rubella virus with an
ELISA, as described previously (11–13).
Due to logistic reasons (fresh blood is
needed for these measurements), in a sub-
group of 85 children monocyte, granulocyte,
and lymphocyte counts were determined by
whole blood fluorescence-activated cell
sorter analysis combined with the determina-
tion of the white blood cell count by a cell
counter. Methods of determination were
described previously (14,15). Analyses were
performed with a FAC-Scan ﬂow cytometer
(Becton Dickinson, San Jose, CA, USA).
Whole blood was incubated with a panel of
optimally titrated ﬂuorescein isothiocyanate
(FITC)- or phycoerythrin (PE)-conjugated
monoclonal antibodies (MAbs) for single or
double immunofluorescence staining. As a
rule, irrelevant IgG2 FITC- or IgG1 PE-
conjugated MAbs were used as negative con-
trols. Before flow cytometric analysis, red
blood cells were lysed with FACS lysing
solution (Becton Dickinson). The MAbs
used in this study, obtained from Becton
Dickinson unless mentioned otherwise, were
as follows: CD19 (Leu-12 PE) and CD20
(B1 FITC; Coulter Clone, Hialeah, FL,
USA) to label B cells; CD3 (Leu-4 FITC),
CD4 (Leu-3 FITC or Leu-3 PE), and CD8
(Leu-2 PE) to label T cells; TcR αβ -FITC
(WT31) and TcR(γδ -FITC (11F2) to label
TcR αβ and TcR γδ cells; CD16 (Leu-11c
PE) and CD56 (Leu-19 PE) to label natural
killer (NK) cells; anti-HLA-DR (L243 PE)
to label activated T cells; and CD14 (My4
PE; Coulter Clone) and CD45 (HLe-1
FITC) to determine, in combination with
the whole-blood forward and side-scatter
patterns, the percentages of granulocytes,
monocytes, and lymphocytes (Leucogate).
Further data analyses were made of the lym-
phocyte population thus deﬁned. This lym-
phocyte population represented at least 95%
of the total number of lymphocytes and con-
tained less than 3% contamination by mono-
cytes. Thus absolute numbers of the following
lymphocyte (sub)populations were deter-
mined: CD3+CD4+ (helper), CD3+CD8+
(cytotoxic), CD3+HLA-DR (activated), TcR
αβ + and TcR γδ +, CD4+CD45RA+ (naive),
and CD4+CD45RO+ (memory) T-lympho-
cytes, B-lymphocytes (CD19+ and/or
CD20+), and NK cells (CD16+and/or
CD56+/CD3–).
Data analysis. We analyzed the data
using the statistical software package SPSS
win 7.5 (SPSS Inc., Chicago, IL). For
dichotomous immunologic variables (health
questionnaire), we used multiple logistic
regression analysis, expressing the effects of
PCB and dioxin levels on the prevalence of
infectious or allergic disease as odds ratio
(OR) per unit increase of levels of PCBs and
dioxins, with 95% confidence interval and
adjustment made for confounding variables.
Based on clinical knowledge and literature
(16,17), the confounding variables included
in these analyses were sex,  early feeding type
(breast-fed or formula-fed), duration of
breast-feeding during infancy (less or more
than 16 weeks), parity (born ﬁrst or second),
maternal education (secondary school not
finished or secondary school or more fin-
ished), and parental occupation (blue-collar
or white-collar), tobacco smoking by one or
both parents, family history of atopy in one
or more parents, and day care or nursery
school attendance for the child. For continu-
ous immunologic variables (antibody levels
and the immunologic marker analysis), we
estimated Pearson correlation coefficients
between the PCB and dioxin levels as well as
the immunologic variables after logarithmic
transformation of both variables involved.
These analyses were performed separately for
prenatal (Σ PCB maternal, Σ PCB cord, and
dioxin, planar, and mono-ortho PCB TEQ
levels) as well as current PCB body burden
(Σ PCB 42 months). Results were considered
statistically signiﬁcant at the p ≤ 0.05 level.
Results
At 42 months of age, 193 children were re-
examined (18). Complete health question-
naires were returned by 175 of the 193
parents (90%). The characteristics of the
study group and levels of Σ PCBs measured
in plasma and of the planar, mono-ortho,
and the dioxin TEQ in breast milk are pre-
sented in Table 1. 
The prevalence of infectious and allergic
diseases is presented in Table 2. According
to parental report of doctors’ diagnoses, 103
(58.9%) of the 175 children had 1 episode
(50th percentile), and 21 (12.0%) had 6
(90th percentile, e.g., recurrent) episodes of
middle-ear infections. Pneumonia was
reported for 5 (2.9%), scarlatina for 13
(7.4%), chicken pox for 130 (74.3%), and
other infectious diseases for 15 (8.6%) (1
meningitis, 1 cystitis, 1 gastroenteritis, 1
lymphadenitis, 3 measles, and 8 common
viral diseases such as exanthema subitum or
erythema infectiosum) of the 175 children.
Hospital admission for infectious diseases
was reported for 7 (4.0%) of the 175 chil-
dren (3 respiratory infections, 1 meningitis,
1 scarlatina, and 2 other viral diseases). Of
the 14 children with allergic reactions, 7 had
shown an allergic reaction to food, 2 to dust,
2 to household pets, 2 to dust and house-
hold pets, and 1 to pollen, dust, and house-
hold pets. Adjusted for confounders (e.g.,
sex, early feeding type, duration of breast-
feeding during infancy, parity, maternal edu-
cation and parental occupation, tobacco
smoking by one or both parents, family his-
tory of atopy in one or more parents, and
day care or nursery school attendance for the
child), a higher Σ PCB maternal was associat-
ed with less shortness of breath with wheeze.
For the Σ PCB cord the results were in the
same direction but not signiﬁcant. Current
PCB body burden was associated with a
higher prevalence of recurrent middle-ear
infections and chicken pox and a lower
prevalence of allergic reactions (Table 2). In
breast milk, the mono-ortho and planar PCB
TEQ had a significant effect on recurrent
middle-ear infections (mono-ortho PCB
TEQ: OR 1.17 , 95% CI, 1.04–1.32, p =
0.01; planar PCB TEQ: OR 1.10, 95% CI,
1.00–1.20, p = 0.04) and the dioxin TEQ
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congestion, and phlegm (OR 1.06, 95% CI,
1.00–1.11, p = 0.04). 
The effects of early feeding type and the
duration breast-feeding on the prevalence of
recurrent middle-ear infections, chicken pox
and allergic reactions and current PCB body
burden are described in Table 3. Although
current PCB body burden was 3–4 times
lower in formula-fed than in breast-fed chil-
dren (median Σ PCB at 42 months was 0.21
vs. 0.75 µg/L), there was no difference in
prevalence of recurrent middle-ear infections,
chicken pox, or allergic reactions between
these two groups. In the breast-fed group
current PCB body burden was 2 times lower
in children breast-fed for 16 weeks than in
children breast-fed for more than 16 weeks
(median Σ PCB at months 0.60 vs. 1.04
µg/L). The effect of current PCB exposure
was counteracted by the effect of the dura-
tion of breast-feeding on the prevalence of
recurrent middle-ear infections and chicken
pox as well as on allergic reactions (Table 3). 
Serum for antibody levels was available in
150 children at 42 months of age. There was
no difference in characteristics between these
150 children and the whole study group, and
the levels of Σ PCBs measured in plasma and
of the dioxin, planar, and mono-ortho TEQ
in breast milk were comparable. Four chil-
dren showed no seroconversion for mumps,
3 for measles, and 2 for rubella at 18 months
of age. These nonseroconverting antibody
concentrations were excluded from further
analysis. Median antibody levels were 94.3
U/mL (range 2.9–2334.1) for mumps; 1.2
IU/mL (range 0.08–12.0) for measles; and
47.0 IU/mL (range 4.3–220.0) for rubella.
After logarithmic transformation of both vari-
ables, antibody levels to mumps were nega-
tively correlated with Σ PCB maternal levels
(Pearson correlation –0.17, p = 0.04) and
antibody levels to rubella were negatively
correlated with Σ PCB cord levels (Pearson
correlation –0.19, p = 0.03). There were no
signiﬁcant correlations between antibody lev-
els and the dioxin, planar, and mono-ortho
PCB TEQ levels separately nor with the
Σ PCB at 42 months of age.
White blood cell counts and immuno-
logic marker analyses of the lymphocytes at
42 months of age were available for a sub-
group of 85 children. Children breast-fed in
infancy were accidentally underrepresented
in this subgroup; consequently the Σ PCB 42
months in this subgroup was lower than in
the whole group (Table 1). The results of the
white blood cell counts and the immunolog-
ic marker analyses of the lymphocytes at 42
months of age in relation to exposure to
PCBs and dioxins are presented in Table 4.
These results were all within the normal
ranges for age-matched children (19). After
logarithmic transformation of both variables,
significant positive correlations between
prenatal PCB exposure and the number of
lymphocytes, T cells, and CD3+CD8+ (cyto-
toxic), CD4+ CD45RO+ (memory), TcR
αβ +, and CD3+HLA-DR+ (activated) T cells
were found for maternal as well as cord plas-
ma. Results were signiﬁcant in the formula-
fed but not in the breast-fed group. There
were no signiﬁcant correlations between the
results of the white blood cell counts and
immunologic marker analyses and the
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Table 1. Characteristics of the study group(s).
Health Immunologic 
questionnaire marker analyses
(n = 175) (n = 85)
Sex (male)a 54 48
Early feeding type (breast-fed)a 52 36
Duration of breast-feeding (weeks)b 17 (6–72) 16 (6–72)
Parity (ﬁrstborn)a 50 41
Maternal education and parental occupation (low)a 66
Tobacco smoking by one or both parents (yes)a 39 46
Family history of atopy in one or both parents (yes)a 73 79
Day care or nursery attendance of the child (yes)a 85 90
Toxic compounds measured in plasma
Σ PCB maternal (µg/L)b 2.07 (0.59–7.35)  1.81 (0.59–4.76) 
(n = 174) (n = 85)
Σ PCB cord (µg/L)b 0.40 (0.08–2.08)  0.35 (0.08–1.98)
(n = 158) (n = 78)
Σ PCB at 42 months (µg/L)b 0.39(0.08–5.90) 0.26  (0.08–2.12)
(n = 158) (n = 84)
Toxic compounds measured in breast milk
Planar PCB TEQ (pg/g milk fat)b 14.9 (4.4–45.7)  17.1 (5.9–45.7) 
(n = 81) (n = 30)
Mono-ortho PCB TEQ (pg/g milk fat)b 14.0 (3.2–44.4)  14.0 (6.4–25.45)
(n = 85) (n = 30)
Dioxin TEQ (pg/g milk fat)b 35.8 (10.2–87.2)  35.1 (15.6–66.6)
(n = 71) (n = 24)
aData are percentages. bData are median (minimum–maximum)
Table 2. Prevalence of infectious and allergic diseases and effects of prenatal and current PCB body burden. 
Prevalence Prenatal PCB exposure Current PCB body burden
n (%) Σ PCB Maternal  Σ PCB at 42 months
(n = 175) OR (95% CI)a p-Value OR (95% CI)a p-Value
Infectious diseases
Middle-ear infections (1 or more episodes) 103 (58.9) 0.89 (0.65–1.23) 0.49 1.27 (0.61–2.64) 0.52
Recurrent middle-ear infections 21 (12.0) 1.37 (0.87–2.17) 0.17 3.06 (1.17–7.98) 0.02*
(6 or more episodes)
Pneumonia 5 (2.9) 0.41 (0.10–1.63) 0.21 0.01 (0.01–29.68) 0.13
Scarlatina 13 (7.4) 1.00 (0.56–1.80) 0.98 0.59 (0.08–4.03) 0.59
Chicken pox 130 (74.3) 1.43 (0.92–2.24) 0.11 7.63 (1.21–48.54) 0.03*
Other infectious diseases 15 (8.6) 1.04 (0.60–1.82) 0.87 0.85 (0.27–2.67) 0.79
Hospital admissions for infectious diseases  7 (4.0) 1.04 (0.44–2.46) 0.93 0.68 (0.01–25.05) 0.37
Allergic diseases
Eczema 42 (24.0) 1.18 (0.82–1.71) 0.37 0.92 (0.41–2.08) 0.84
Allergic reaction  14 (8.0) 0.62 (0.29–1.32) 0.22 0.01 (0.01–0.37) 0.01*
Asthma or bronchitis 30 (17.1) 0.87 (0.55–1.40) 0.56 0.38 (0.06–2.57) 0.32
Coughing, chest congestion, or 
phlegm lasting for 10 days or moreb 48 (27.4) 1.08 (0.75–1.54) 0.69 1.12 (0.58–2.16) 0.74
Attacks of shortness of breath with wheezeb 17 (9.7) 0.44 (0.18–0.99) 0.05* 0.34 (0.02–4.49) 0.41
aCorrected for sex, early feeding type (breast-fed or formula-fed), duration of breast-feeding during infancy (less or more than 16 weeks), parity (ﬁrstborn or second born), maternal edu-
cation and parental occupation (low), tobacco smoking by one or both parents (yes or no), family history of atopy in one or more parents (yes or no), and day care or nursery school
attendance for the child (yes or no). bIn the previous 12 months. *Signiﬁcant at the ≤ 0.05 level. dioxin, planar, and mono-ortho PCB TEQ
levels separately nor with the Σ PCB at 42
months of age. 
Discussion
Our exploratory study demonstrates for the
ﬁrst time that health effects may occur from
“normal”’ environmental PCB exposure in
preschool children. Current PCB body bur-
den is inﬂuenced mainly by lactational trans-
fer (3) and associated with a higher prevalence
of recurrent middle-ear infections and of a
common viral disease like chicken pox. A
higher dioxin TEQ was associated with a
higher prevalence of coughing, chest conges-
tion, and phlegm. In Inuit infants, whose
mothers have high levels of organochlorine
compounds in their breast milk, perinatal
organochlorine exposure was also associated
with more acute otitis media (7). In these
highly exposed infants, however, the preva-
lence of at least one episode of middle-ear
infection during the ﬁrst year of life (80%) is
much higher than in our study of Dutch
preschool children (60%). Breast-feeding dur-
ing 4 months or more has been associated
with lower rates of middle-ear and other
infectious diseases during infancy (20), and
the ﬁrst middle-ear infection occurred earlier
in children who were weaned before 6
months of age (21). In our study, half of the
children were already weaned before 4
months and 70 percent before 6 months of
age; the positive effect of breast-feeding on
recurrent middle-ear infections was counter-
acted by the negative effect of PCB exposure.
Prenatal PCB exposure was also associat-
ed with a lower prevalence of attacks of
shortness of breath with wheeze, and current
PCB body burden was associated with a
lower prevalence of allergic reactions to food,
pollen, dust, and/or household pets. Respira-
tory symptoms are frequent in very young
children and the relation of these symptoms
to later asthma is unknown. However,
attacks of shortness of breath with wheeze
through ages 3–4 are associated with the sub-
sequent diagnosis of asthma (22). Among
Japanese schoolchildren, a positive tuberculin
response predicted a lower incidence of asth-
ma (23); in African children measles infec-
tion possibly prevented the development of
atopy (24); and in Italy the prevalence of
atopy was low among Hepatitis A seroposi-
tive subjects (25). Common infections
acquired early in life paradoxically might pre-
vent the development of atopy (26), so PCB
exposure may be associated with a greater
susceptibility to infectious as well as a lower
prevalence of allergic diseases.
In our study prenatal PCB exposure was
associated with a higher number of CD8+
(cytotoxic) and TcR αβ + T cells at 42 months
of age. In the study of Inuit infants no associ-
ation between organochlorine exposure and
immunologic parameters was found (7). The
cellular analyses of the Inuit study are not
strictly comparable with our method, and our
results are consistent with in vitro studies,
where exposure to PCBs and dioxins may
change the kinetics of thymocyte maturation
and skew the thymocyte differentiation
toward CD8+ phenotypically more mature
TcR αβ + T cells (27). Prenatal PCB exposure
was also significantly correlated with more
CD4+CD45RO+ (memory) and CD3+HLA-
DR+ (activated) T cells as well as subtle
changes in levels of antibody to mumps and
rubella after primary vaccinations. These ﬁnd-
ings may indicate a greater susceptibility to
infectious diseases in early childhood. In ani-
mals an impaired host resistance to infectious
diseases in relation to exposure to PCBs and
dioxins has also been found. In seals fed by
contaminated Baltic herring, an impairment
of natural killer (NK) cell activity, in vitro T-
lymphocyte function, in vivo delayed-type
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Table 3. Effects of early feeding type and the duration breast-feeding on the prevalence of middle-ear infections, chicken pox, and allergic reactions and current
PCB body burden.
Early feeding type (n = 175) Duration of breast-feeding (n = 91)
Formula-fed Breast-fed Formula-fed Short Long 
(n = 84) (n = 91) vs. breast-fed (n = 44) (n = 47) Short vs. long
Prevalence Prevalence OR (95% CI)a p-Value Prevalence Prevalence OR (95% CI)b p-Value
Recurrent middle-ear infections 9 (10.7) 12 (13.2) 1.03 (0.29–3.61) 0.96 6 (13.6) 6 (12.8) 0.12 (0.01–1.07) 0.06
Chicken pox 58 (69.0) 72 (79.1) 0.67 (0.21–2.14) 0.51 36 (81.8) 36 (76.6) 0.23 (0.05–1.08) 0.06
Allergic reaction  8 (9.5) 6 (6.6) 0.86 (0.08–9.48) 0.90 2 (4.5) 4 (8.5) 26.9 (0.74–978.8) 0.07
Σ PCB at 42 months( µg/L) 0.21 (0.08–0.46) 0.75 (0.23–5.90) 0.60 (0.24–1.15) 1.04 (0.23–5.90)
median (minimum–maximum)
Prevalence is shown as number (percent). For duration of breast-feeding, short = 6–16 weeks and long = > 16 weeks.
aCorrected for Σ PCB at 42 months, sex, duration of breast-feeding during infancy (less or more than 16 weeks), parity (ﬁrstborn or second born), maternal education and parental occu-
pation (low), tobacco smoking by one or both parents (yes or no) , family history of atopy in one or more parents (yes or no), and day care or nursery school attendance for the child (yes
or no). bCorrected for Σ PCB at 42 months, sex, parity (ﬁrstborn or second born), maternal education and parental occupation (low), tobacco smoking by one or both parents (yes or no) ,
family history of atopy in one or more parents (yes or no), and day care or nursery school attendance for the child (yes or no). 
Table 4. Results of the white blood cell counts and the immunologic marker analysis (n = 85) in relation to prenatal PCB exposure.
Absolute counts Prenatal PCB exposure
Percentiles (109/L) Σ PCB maternal Σ PCB cord
White blood cells 5th 50th 95th Pearson correlationa p-Value Pearson correlationa p-Value
Monocytes 0.3 0.5 0.9 0.04 0.73 0.09 0.43
Granulocytes 2.2 4.1 7.5 0.14 0.22 0.15 0.20
Lymphocytes 2.2 4.1 6.6 0.25 0.02* 0.22 0.05*
T-cell markers
CD3+ 1.4 2.7 4.6 0.25 0.02* 0.21 0.07
CD3+CD4+ 0.8 1.7 2.7 0.19 0.08 0.16 0.17
CD3+CD8+ 0.4 0.9 1.7 0.27 0.01* 0.24 0.04*
CD4+CD45RA+ 0.3 1.0 1.9 0.12 0.26 0.04 0.77
CD4+CD45RO+ 0.2 0.4 0.6 0.25 0.02* 0.26 0.02*
TcR αβ + 1.1 2.5 4.2 0.25 0.02* 0.20 0.08
TcR γδ + 0.1 0.2 0.4 0.17 0.12 0.15 0.20
CD3 +HLA-DR+ 0.1 0.3 0.5 0.26 0.02* 0.31 0.005*
B-cell markers
CD 19/20+ 0.4 0.9 1.7 0.12 0.28 0.15 0.20
NK-cell markers
CD16+ and/or CD56+/CD3– 0.1 0.3 1.1 0.13 0.23 0.11 0.31
aAfter logarithmic transformation of both variables involved. *Signiﬁcant at the ≤ 0.05 level.hypersensitivity, and antibody responses to
ovalbumin was observed (28). In our human
study T-lymphocyte functions and direct
hypersensitivity responses were not tested and
should be subject to further study. 
The PCBs 118, 138, 153, and 180 are the
four most abundant congeners, constituting
46 percent of the total PCBs (29) and repre-
senting a complex mixture of interrelated
environmental xenobiotics. To get an indica-
tion about possible immunotoxicants other
than PCBs and dioxins, we measured lead
and cadmium at 18 months of age. Mean lev-
els were low (Cd mean 0.5 µg/dL, Pb mean
4.8 µg/dL) and not related to the outcome
variables. These measurements were therefore
not repeated at 42 months of age. In our
study, at 18 months of age the number of
CD8+ (cytotoxic) and TcR αβ + T cells corre-
lated best with the dioxin TEQ levels, while
at 42 months of age there was no signiﬁcant
relation with the dioxin TEQ levels (Pearson
correlation 0.11 and 0.16). However, the
number of CD8+ (cytotoxic) and TcR αβ + T
cells at 18 and 42 months of age was signiﬁ-
cantly correlated (Pearson correlation 0.64
and 0.63, p < 0.0001); at preschool age the
Σ PCB maternal and Σ PCB cord were associ-
ated with an increased number of CD8+
(cytotoxic), CD4+CD45RO+ (memory), TcR
αβ +, and CD3+HLA-DR+ (activated) T cells
in the formula-fed group only. For logistic
reasons immunologic marker analysis could
be done in only 85 children. Breast-fed
infants were accidentally underrepresented in
this subgroup, so no relation with the dioxin,
planar, and mono-ortho PCB toxic equivalent
(TEQ) levels in human milk was found.
Immunotoxicologic studies are usually per-
formed in laboratory animals, exposing them
to a range of concentrations of potentially
immunotoxic compound. In the environment
PCBs and dioxins are present as complex
mixtures of various congeners, which may
vary in metabolism and toxicity. Moreover,
PCBs form persistent and abundant metabo-
lites that accumulate in biota. Limited infor-
mation is available on the immunotoxic
effects of chronic background exposure to
such complex mixtures of xenobiotics in the
human food chain and, besides PCBs and
dioxins, other related organochlorine com-
pounds might also be responsible for the
observed associations.
In conclusion, the effects of perinatal
background exposure to PCBs and dioxins
persist into childhood and might be associ-
ated with a greater susceptibility to infec-
tious diseases. Common infections acquired
early in life may prevent the development of
allergy, and therefore PCB exposure might
be associated with a lower prevalence of
allergic diseases. In our study the negative
effect of a higher postnatal PCB exposure was
counteracted by the positive effect of a longer
duration of breast-feeding in infancy.
Moreover, as described previously, breast-fed
children in our study did better in neurologi-
cal (30) and cognitive outcome (18) than
their formula-fed counterparts did. Our study
does not provide data to discourage breast-
feeding at present background PCB levels.
Although most of the above-mentioned
immunologic changes seen in preschool chil-
dren may be subtle, these data indicate that
human children might be susceptible to
immunotoxic pollutants and that, due to pre-
sent levels of PCBs and dioxins in the food
chain, health effects may occur. These effects
are important from a public health perspec-
tive because large population groups are
exposed. Perinatal exposure to PCBs, dioxins,
and related compounds should therefore be
lowered by reducing the intake through the
food chain at all ages, rather than by discour-
aging breast-feeding. Long-term follow-up
studies of perinatally exposed cohorts should
be conducted into later childhood, through
puberty, and into adulthood to investigate the
implications of our ﬁndings.
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